Lauder In-House Counsel: Start Planning For Supply Chain Quality Agreements Under MoCRA
Executive Summary
Companies that have struggled to secure quality agreements with suppliers have additional leverage and a new starting point for those discussions, namely the Modernization of Cosmetic Regulations Act. Anand Natarajan, associate counsel at The Estee Lauder Companies, provided his view in a recent FDLI webinar.
You may also be interested in...
US FDA Seeks Input On Cosmetics GMP Development, Industry Costs, Likely Safety Impacts
The agency is accepting comments from 27 April to 3 July 2023 to Docket No. FDA-2023-N-1466 to inform its development of good manufacturing practices for facilities that manufacture or process cosmetic products distributed in the United States. A virtual “listening session” is slated for 1 June.
Getting A Jump On MoCRA Compliance; Due Diligence Now Will Lighten Load, Risks Later
Cosmetics companies should not sit idly waiting for FDA to clarify new requirements under the Modernization of Cosmetic Regulations Act, speakers agreed at the Independent Beauty Association’s 2023 Technical/Regulatory Forum. Companies should be reviewing products, people and processes, including those of contract manufacturers, to get ahead of the curve.
NSF Leaders On How New Cosmetics Certification Could Bolster MoCRA Compliance
NSF’s Contents and Claims Certified Guideline for beauty and personal-care products should position companies well for compliance with new US regulations under the Modernization of Cosmetic Regulations Act, the organization says. NSF senior leaders discuss in an interview with HBW Insight.